Preparation of amyloid-like fibrils containing magnetic iron oxide nanoparticles: Effect of protein aggregation on proton relaxivity

Biochemical and Biophysical Research Communications

Volumn 419, Issue 4, 2012, Pages 682-686

  Viktor Andersson, B ^a   Skoglund, Caroline ^a   Uvdal, Kajsa ^a   Solin, Niclas ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Amyloid fibrils; Electron tomography; Magnetic nanoparticles; Proton relaxation; Self assembly

Indexed keywords

AMYLOID; AMYLOID LIKE FIBRIL; MAGNETIC IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLE; PROTON; UNCLASSIFIED DRUG;

ARTICLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; ANIMALS; CATTLE; FERRIC COMPOUNDS; INSULIN; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOTECHNOLOGY; PROTEINS; PROTONS;

EID: 84858745162     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.077     Document Type: Article

References (30)

1. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 2009, 21:2133.
2. Hergt R., Hiergeist R., Hilger I., Kaiser W.A., Lapatnikov Y., Margel S., Richter U. Maghemite nanoparticles with very high ac-losses for applications in rf-magnetic hyperthermia. J. Magn. Magn. Mater. 2004, 270:345-357.
3. Amstad E., Textor M., Reimhult E. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications. Nanoscale 2011, 3:2819-2843.
4. Chemla Y.R., Grossman H.L., Poon Y., McDermott R., Stevens R., Alper M.D., Clarke J. Ultrasensitive magnetic biosensor for homogeneous immunoassay. Proc. Natl. Acad. Sci. 2000, 97:14268-14272.
5. De M., Gosh P.S., Rotello V.M. Applications of nanoparticles in biology. Adv. Mater. 2008, 20:4225-4241.
6. Stark W.J. Nanoparticles in biological systems. Angew. Chem. Int. Ed. 2011, 50:1242-1258.
7. Kushner A.M., Guan Z. Modular design in natural and biomimetic soft materials. Angew. Chem. Int. Ed. 2011, 50:9026-9057.
8. Knowles T.P.J., Buehler M.J. Nanomechanics of functional and pathological amyloid materials. Nat. Nanotechnol. 2011, 6:469-479.
9. Cherny I., Gazit E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed. 2008, 47:4062-4069.
10. Rizzo A., Inganäs O., Solin N. Preparation of phosphorescent amyloid-like protein fibrils. Chem. Eur. J. 2010, 16:4190-4195.
11. Rizzo A., Solin N., Lindgren L.J., Andersson M.R., Inganäs O. White light with phosphorescent protein fibrils in olds. Nano Lett. 2010, 10:2225-2230.
12. Skaat H., Sorci M., Belfort G., Margel S. Effect of maghemite nanoparticles on insulin amyloid fibril formation: selective labeling, kinetics, and fibril removal by a magnetic field. J. Biomed. Mater. Res. A 2009, 91A:342-351.
13. Bellova A., Bystrenova E., Koneracka M., Kopcansky P., Valle F., Tomasovicova N., Timko M., Bagelova J., Biscarini F., Gazova Z. Effect of Fe3O4 magnetic nanoparticles on lysozyme amyloid aggregation. Nanotechnology 2010, 21:065103.
14. Skaat H., Belfort G., Margel S. Synthesis and characterization of fluorinated magnetic core-shell nanoparticles for inhibition of insulin amyloid fibril formation. Nanotechnology 2009, 20:225106.
15. Skaat H., Margel S. Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-β fibrils detection and removal by a magnetic field. Biochem. Biophys. Res. Commun. 2009, 386:645-649.
16. Jiménez J.L., Nettleton E.J., Bouchard M., Robinson C.V., Dobson C.M., Salbil H.R. The protofilament structure of insulin amyloid fibrils. Proc. Natl. Acad. Sci. 2002, 99:9196-9201.
17. Orlova E.V., Saibil H.R. Structural analysis of macromolecular assemblies by electron microscopy. Chem. Rev. 2011, 111:7710-7748.
18. Levine H. Thioflavine T interaction with synthetic Alzheimer's disease b-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993, 2:404-410.
19. H. Friebolin, in: Basic One- and Two-Dimensional NMR Spectroscopy, Wiley-VCH, Weinheim, 2005.
20. Britton M.B. Magnetic resonance imaging of chemistry. Chem. Soc. Rev. 2010, 39:4036-4043.
21. Que E.L., Chang C.J. Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicine. Chem. Soc. Rev. 2010, 39:51-60.
22. Yan G.-P., Robinson L., Hogg P. Magnetic resonance imaging contrast agents: overview and perspectives. Radiography 2007, 13:e5-e19.
23. Bulte J.W.M., Douglas T., Mann S., Frankel R.B., Moskowitz B.M., Brooks R.A., Baumgartner C.D., Vymazal J., Strub M.-P., Frank J.A., Magnetoferritin J. Characterization of a novel superparamagnetic MR contrast agent. Magn. Reson. Imaging 1994, 4:497-505.
24. 2 relaxation. ACS Nano 2011, 5:3104-3112.
25. Wall J.S., Richey T., Stuckey A., Donnel R., Macy S., Martin E.B., Williams A., Higuchi K., Kennel S.J. In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides. Proc. Natl. Acad. Sci. 2011, 108:E586-E594.
26. Solomon A., Richey T., Murphy C.L., Weiss D.T., Wall J.S., Westermark G.T., Westermark P. Amyloidogenic potential of foie grass. Proc. Natl. Acad. Sci. 2007, 104:10998-11001.
27. Pearce F.G., Mackintosh S.H., Gerrard J.A. Formation of amyloid-like fibrils by ovalbumin and related proteins under conditions relevant to food processing. J. Agric. Food Chem. 2007, 55:318-322.
28. Westermark G.T., Westermark P. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis. FEBS Letters 2009, 583:2685-2690.
29. Akkermans C., Van der Goot A.J., Venema P., Gruppen H., Vereijken J.M., Van der Linden E., Boom R.M. Micrometer-sized fibrillar protein aggregates from soy glycinin and soy protein isolate. J. Agric. Food Chem. 2007, 55:9877-9882.
30. A. Kroes-Nijboer, P. Venema, E. van der Linden, Fibrillar structures in food, Food Funct. 2012, (). doi:10.1039/c1fo10163c.